230 related articles for article (PubMed ID: 19509285)
1. Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt.
Wegiel B; Baty CJ; Gallo D; Csizmadia E; Scott JR; Akhavan A; Chin BY; Kaczmarek E; Alam J; Bach FH; Zuckerbraun BS; Otterbein LE
J Biol Chem; 2009 Aug; 284(32):21369-78. PubMed ID: 19509285
[TBL] [Abstract][Full Text] [Related]
2. Biliverdin inhibits Toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductase.
Wegiel B; Gallo D; Csizmadia E; Roger T; Kaczmarek E; Harris C; Zuckerbraun BS; Otterbein LE
Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18849-54. PubMed ID: 22042868
[TBL] [Abstract][Full Text] [Related]
3. Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway.
Pachori AS; Smith A; McDonald P; Zhang L; Dzau VJ; Melo LG
J Mol Cell Cardiol; 2007 Nov; 43(5):580-92. PubMed ID: 17920074
[TBL] [Abstract][Full Text] [Related]
4. Go green: the anti-inflammatory effects of biliverdin reductase.
Wegiel B; Otterbein LE
Front Pharmacol; 2012; 3():47. PubMed ID: 22438844
[TBL] [Abstract][Full Text] [Related]
5. Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.
Reed JR; Huber WJ; Backes WL
Drug Metab Dispos; 2010 Nov; 38(11):2060-6. PubMed ID: 20679134
[TBL] [Abstract][Full Text] [Related]
6. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD
FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089
[TBL] [Abstract][Full Text] [Related]
7. Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease.
Sharma N; Tramutola A; Lanzillotta C; Arena A; Blarzino C; Cassano T; Butterfield DA; Di Domenico F; Perluigi M; Barone E
Neurobiol Dis; 2019 May; 125():176-189. PubMed ID: 30738142
[TBL] [Abstract][Full Text] [Related]
8. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells.
Miralem T; Hu Z; Torno MD; Lelli KM; Maines MD
J Biol Chem; 2005 Apr; 280(17):17084-92. PubMed ID: 15741166
[TBL] [Abstract][Full Text] [Related]
9. Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt.
Zeng R; Yao Y; Han M; Zhao X; Liu XC; Wei J; Luo Y; Zhang J; Zhou J; Wang S; Ma D; Xu G
J Am Soc Nephrol; 2008 Feb; 19(2):380-7. PubMed ID: 18184861
[TBL] [Abstract][Full Text] [Related]
10. Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.
Maghzal GJ; Leck MC; Collinson E; Li C; Stocker R
J Biol Chem; 2009 Oct; 284(43):29251-9. PubMed ID: 19690164
[TBL] [Abstract][Full Text] [Related]
11. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin.
Jansen T; Hortmann M; Oelze M; Opitz B; Steven S; Schell R; Knorr M; Karbach S; Schuhmacher S; Wenzel P; Münzel T; Daiber A
J Mol Cell Cardiol; 2010 Aug; 49(2):186-95. PubMed ID: 20430037
[TBL] [Abstract][Full Text] [Related]
12. Biliverdin reductase as a target in drug research and development: Facts and hypotheses.
Mancuso C
Free Radic Biol Med; 2021 Aug; 172():521-529. PubMed ID: 34224815
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway.
Bisht K; Canesin G; Cheytan T; Li M; Nemeth Z; Csizmadia E; Woodruff TM; Stec DE; Bulmer AC; Otterbein LE; Wegiel B
J Immunol; 2019 May; 202(10):2982-2990. PubMed ID: 30952817
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of biliverdin reductase enhances resistance to chemotherapeutics.
Florczyk U; Golda S; Zieba A; Cisowski J; Jozkowicz A; Dulak J
Cancer Lett; 2011 Jan; 300(1):40-7. PubMed ID: 20934804
[TBL] [Abstract][Full Text] [Related]
15. The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.
Barone E; Di Domenico F; Mancuso C; Butterfield DA
Neurobiol Dis; 2014 Feb; 62():144-59. PubMed ID: 24095978
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin.
Kapitulnik J; Maines MD
Trends Pharmacol Sci; 2009 Mar; 30(3):129-37. PubMed ID: 19217170
[TBL] [Abstract][Full Text] [Related]
17. Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways.
Maines MD
Antioxid Redox Signal; 2007 Dec; 9(12):2187-95. PubMed ID: 17919068
[TBL] [Abstract][Full Text] [Related]
18. Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance.
Florczyk UM; Jozkowicz A; Dulak J
Pharmacol Rep; 2008; 60(1):38-48. PubMed ID: 18276984
[TBL] [Abstract][Full Text] [Related]
19. Biliverdin Reductase A (BVRA) Mediates Macrophage Expression of Interleukin-10 in Injured Kidney.
Hu Z; Pei G; Wang P; Yang J; Zhu F; Guo Y; Wang M; Yao Y; Zeng R; Liao W; Xu G
Int J Mol Sci; 2015 Sep; 16(9):22621-35. PubMed ID: 26393580
[TBL] [Abstract][Full Text] [Related]
20. Biliverdin reductase/bilirubin mediates the anti-apoptotic effect of hypoxia in pulmonary arterial smooth muscle cells through ERK1/2 pathway.
Song S; Wang S; Ma J; Yao L; Xing H; Zhang L; Liao L; Zhu D
Exp Cell Res; 2013 Aug; 319(13):1973-1987. PubMed ID: 23722043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
